Table of Contents Author Guidelines Submit a Manuscript
Journal of Oncology
Volume 2009, Article ID 895381, 10 pages
http://dx.doi.org/10.1155/2009/895381
Research Article

TJ-41 Induces Apoptosis and Potentiates the Apoptotic Effects of 5-FU in Breast Cancer Cell Lines

1Division of Basic Research, South Carolina Cancer Center, 14 Medical Park, Suite 500, Columbia, SC 29203, USA
2Division of Cell and Molecular Pharmacology, Hollings Cancer Center, 86 Jonathan Lucas St., HO712H Charleston, SC 29425, USA

Received 16 July 2008; Revised 29 January 2009; Accepted 26 May 2009

Academic Editor: Thomas J. Fahey

Copyright © 2009 Suresh Volate et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. O. Ganry, “Phytoestrogen and breast cancer prevention,” European Journal of Cancer Prevention, vol. 11, no. 6, pp. 519–522, 2002. View at Publisher · View at Google Scholar
  2. K. A. Cronin, B. Yu, M. Krapcho et al., “Modeling the dissemination of mammography in the United States,” Cancer Causes and Control, vol. 16, no. 6, pp. 701–712, 2005. View at Publisher · View at Google Scholar
  3. M. A. Richardson, T. Sanders, J. L. Palmer, A. Greisinger, and S. E. Singletary, “Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology,” Journal of Clinical Oncology, vol. 18, pp. 2505–2514, 2000. View at Google Scholar
  4. H. Oka, S. Yamamoto, T. Kuroki et al., “Prospective study of chemoprevention of hepatocellular carcinoma with Sho- saiko-to (TJ-9),” Cancer, vol. 76, no. 5, pp. 743–749, 1995. View at Publisher · View at Google Scholar
  5. V. S. Sierpina, “Use of herbal medications before surgery,” Journal of the American Medical Association, vol. 286, no. 20, pp. 2543–2544, 2001. View at Google Scholar
  6. X. Q. Wang, T. Takahashi, S. J. Zhu et al., “Effect of Hochu-ekki-to (TJ-41), a Japanese Herbal Medicine, on Daily Activity in a Murine Model of Chronic Fatigue Syndrome,” Evidence-Based Complementary and Alternative Medicine, vol. 1, pp. 203–206, 2004. View at Google Scholar
  7. H. Ito and K. Shimura, “Studies on antitumor activity of traditional Chinese medicines (I),” Japanese Journal of Cancer and Chemotherapy, vol. 12, no. 11, pp. 2145–2148, 1985. View at Google Scholar
  8. H. Ito and K. Shimura, “Studies on antitumor activity of traditional Chinese medicines (II). Antitumor mechanism of traditional Chinese medicines,” Japanese Journal of Cancer and Chemotherapy, vol. 12, no. 11, pp. 2149–2154, 1985. View at Google Scholar
  9. H. Fushiki, “Kampo therapy for side effects of gynecologic carcinomatous chemotherapy,” Nippon Rinsho, vol. 62, supplement 10, pp. 623–626, 2004. View at Google Scholar
  10. S.-T. Kao, C.-C. Yeh, C.-C. Hsieh et al., “The Chinese medicine Bu-Zhong-Yi-Qi-Tang inhibited proliferation of hepatoma cell lines by inducing apoptosis via G0/G1 arrest,” Life Sciences, vol. 69, no. 13, pp. 1485–1496, 2001. View at Publisher · View at Google Scholar
  11. M. Harada, K. Seta, O. Ito et al., “Concomitant immunity against tumor development is enhanced by the oral administration of a kampo medicine, Hochu-ekki-to (TJ-41: Bu-Zhong-Yi-Qi-Tang),” Immunopharmacology and Immunotoxicology, vol. 17, no. 4, pp. 687–703, 1995. View at Google Scholar
  12. Y. Tokura, M. Sakurai, H. Yagi, F. Furukawa, and M. Takigawa, “Systemic administration of Hochu-ekki-to (Bu-Zhong-Yi-Qi-Tang), a Japanese-Chinese herbal medicine, maintains interferon-γ production by peripheral blood mononuclear cells in patients with mycosis fungoides,” Journal of Dermatology, vol. 25, no. 2, pp. 131–133, 1998. View at Google Scholar
  13. D. B. Longley, D. P. Harkin, and P. G. Johnston, “5-fluorouracil: mechanisms of action and clinical strategies,” Nature Reviews Cancer, vol. 3, no. 5, pp. 330–338, 2003. View at Publisher · View at Google Scholar
  14. G. Brandi, G. F. Schiavano, N. Zaffaroni et al., “Mechanisms of action and antiproliferative properties of Brassica oleracea juice in human breast cancer cell lines,” Journal of Nutrition, vol. 135, no. 6, pp. 1503–1509, 2005. View at Google Scholar
  15. I. Nicoletti, G. Migliorati, M. C. Pagliacci, F. Grignani, and C. Riccardi, “A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry,” Journal of Immunological Methods, vol. 139, no. 2, pp. 271–279, 1991. View at Publisher · View at Google Scholar
  16. J. Ludbrook, “Multiple comparison procedures updated,” Clinical and Experimental Pharmacology and Physiology, vol. 25, no. 12, pp. 1032–1037, 1998. View at Google Scholar
  17. A. Mansouri, L. D. Ridgway, A. L. Korapati et al., “Sustained activation of JNK/p38 MAPK pathways in response to cisplatin leads to Fas ligand induction and cell death in ovarian carcinoma cells,” Journal of Biological Chemistry, vol. 278, pp. 19245–19256, 2003. View at Google Scholar
  18. G. Schwartsmann, M. J. Ratain, G. M. Cragg et al., “Anticancer drug discovery and development throughout the world,” Journal of Clinical Oncology, vol. 20, pp. 47S–59S, 2002. View at Google Scholar
  19. H. Fushiki, “Kampo therapy for side effects of gynecologic carcinomatous chemotherapy,” Nippon Rinsho, vol. 62, supplement 10, pp. 623–626, 2004. View at Google Scholar
  20. C. K. Osborne, “Steroid hormone receptors in breast cancer management,” Breast Cancer Research and Treatment, vol. 51, no. 3, pp. 227–238, 1998. View at Publisher · View at Google Scholar
  21. P. Nuntanakorn, B. Jiang, L. S. Einbond et al., “Polyphenolic constituents of Actaea racemosa,” Journal of Natural Products, vol. 69, no. 3, pp. 314–318, 2006. View at Publisher · View at Google Scholar
  22. S. C. Kang, C. M. Lee, H. Choi et al., “Evaluation of oriental medicinal herbs for estrogenic and antiproliferative activities,” Phytotherapy Research, vol. 20, no. 11, pp. 1017–1019, 2006. View at Publisher · View at Google Scholar
  23. M. L. King, S. R. Adler, and L. L. Murphy, “Extraction-dependent effects of American ginseng (Panax quinquefolium) on human breast cancer cell proliferation and estrogen receptor activation,” Integrative Cancer Therapies, vol. 5, no. 3, pp. 236–243, 2006. View at Publisher · View at Google Scholar
  24. M. Saito, S. J. Korsmeyer, and P. H. Schlesinger, “BAX-dependent transport of cytochrome C reconstituted in pure liposomes,” Nature Cell Biology, vol. 2, no. 8, pp. 553–555, 2000. View at Publisher · View at Google Scholar
  25. S. H. Kaufmann, “Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin, and other cytotoxic anticancer drugs: a cautionary note,” Cancer Research, vol. 49, no. 21, pp. 5870–5878, 1989. View at Google Scholar
  26. L. A. Smets, “Programmed cell death (apoptosis) and response to anti-cancer drugs,” Anti-Cancer Drugs, vol. 5, no. 1, pp. 3–9, 1994. View at Google Scholar
  27. M. O. Hengartner, “The biochemistry of apoptosis,” Nature, vol. 407, no. 6805, pp. 770–776, 2000. View at Publisher · View at Google Scholar
  28. J. M. Jürgensmeier, Z. Xie, Q. Deveraux, L. Ellerby, D. Bredesen, and J. C. Reed, “Bax directly induces release of cytochrome c from isolated mitochondria,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 9, pp. 4997–5002, 1998. View at Publisher · View at Google Scholar
  29. M. Saito, S. J. Korsmeyer, and P. H. Schlesinger, “BAX-dependent transport of cytochrome C reconstituted in pure liposomes,” Nature Cell Biology, vol. 2, no. 8, pp. 553–555, 2000. View at Publisher · View at Google Scholar
  30. B. W. Zanke, K. Boudreau, E. Rubie et al., “The stress-activated protein kinase pathway mediates cell death following injury induced by cis-platinum, UV irradiation or heat,” Current Biology, vol. 6, no. 5, pp. 606–613, 1996. View at Google Scholar
  31. M. Verheij, R. Bose, X. H. Lin et al., “Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis,” Nature, vol. 380, no. 6569, pp. 75–79, 1996. View at Publisher · View at Google Scholar
  32. Y.-R. Chen, X. Wang, D. Templeton, and R. J. Davis, “The role of c-Jun N-terminal kinase (JNK) in apoptosis induced by ultraviolet C and γ radiation. Duration of JNK activation may determine cell death and proliferation,” Journal of Biological Chemistry, vol. 271, no. 50, pp. 31929–31936, 1996. View at Publisher · View at Google Scholar
  33. R. Yu, A. A. Shtil, T.-H. Tan, I. B. Roninson, and A.-N. T. Kong, “Adriamycin activates c-jun N-terminal kinase in human leukemia cells: a relevance to apoptosis,” Cancer Letters, vol. 107, no. 1, pp. 73–81, 1996. View at Publisher · View at Google Scholar
  34. B. W. Zanke, K. Boudreau, E. Rubie et al., “The stress-activated protein kinase pathway mediates cell death following injury induced by cis-platinum, UV irradiation or heat,” Current Biology, vol. 6, no. 5, pp. 606–613, 1996. View at Google Scholar
  35. M. Verheij, R. Bose, X. H. Lin et al., “Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis,” Nature, vol. 380, no. 6569, pp. 75–79, 1996. View at Publisher · View at Google Scholar
  36. Z. G. Liu, H. Hsu, D. V. Goeddel, and M. Karin, “Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-κB activation prevents cell death,” Cell, vol. 87, no. 3, pp. 565–576, 1996. View at Publisher · View at Google Scholar
  37. H. K. Chew, “Medical management of breast cancer: today and tomorrow,” Cancer Biotherapy and Radiopharmaceuticals, vol. 17, no. 2, pp. 137–149, 2002. View at Google Scholar
  38. F. Guano, P. Pourquier, S. Tinelli et al., “Topoisomerase poisoning activity of novel disaccharide anthracyclines,” Molecular Pharmacology, vol. 56, no. 1, pp. 77–84, 1999. View at Google Scholar
  39. I. Müller, D. Niethammer, and G. Bruchelt, “Anthracycline-derived chemotherapeutics in apoptosis and free radical cytotoxicity (review),” International Journal of Molecular Medicine, vol. 1, no. 2, pp. 491–494, 1998. View at Google Scholar
  40. S. Gamen, A. Anel, P. Pérez-Galán et al., “Doxorubicin treatment activates a Z-VAD-sensitive caspase, which causes ??m loss, caspase-9 activity, and apoptosis in Jurkat cells,” Experimental Cell Research, vol. 258, no. 1, pp. 223–235, 2000. View at Publisher · View at Google Scholar
  41. Y. Lu, M. Tatsuka, H. Takebe, and T. Yagi, “Involvement of cyclin-dependent kinases in doxorubicin-induced apoptosis in human tumor cells,” Molecular Carcinogenesis, vol. 29, no. 1, pp. 1–7, 2000. View at Publisher · View at Google Scholar
  42. R. Morse, J. Rodgers, M. Verrill, and K. Kendell, “Neuropsychological functioning following systemic treatment in women treated for breast cancer: a review,” European Journal of Cancer, vol. 39, no. 16, pp. 2288–2297, 2003. View at Publisher · View at Google Scholar
  43. K. R. Martin, “Targeting apoptosis with dietary bioactive agents,” Experimental Biology and Medicine, vol. 231, no. 2, pp. 117–129, 2006. View at Google Scholar